In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
ICON unveils latest version of its Digital Platform
This news article, published on Contract Pharma, reports on the latest release of the ICON Digital Platform, which supports the integration of ICON patient, site and sponsor services with the delivery of harmonized data and can be customised for any study design, from traditional to fully decentralised.
-
The top 25 healthcare technology leaders of New Jersey for 2023
Steve Cutler, CEO and Helen Yeardley, Senior Vice President, Global Clinical Operations feature in the The Healthcare Technology Report’s listing of the top 25 healthcare technology leaders of New Jersey for 2023.
-
Regulatory considerations in technology for decentralised clinical trials
This article in the Journal of mHealth explores the guidance regulators have provided for diversity and inclusion in clinical trials, privacy considerations and endpoint selection, and is authored by Jo Hulbert, Executive Director, Global Regulatory Clinical Services with contributions from Arwa Shurrab, Senior Director, Global Regulatory Affairs and Priti Prasad, Senior Manager, Global Regulatory Affairs.
Copyright 2023 The Journal of mHealth (Simedics Ltd)
-
Bioanalytical outsourcing soars as drugs grow more complex
Radboud van Trigt, Senior Director of Bioanalytical Science, contributes to this article in Contract Pharma that looks at trends in bioanalytic outsourcing against the backdrop of the increasingly complex nature of modern-day therapeutics.
-
Moving closer to dynamic drug development
Dr Ute Berger, President of Development and Commercialisation Solutions and Ted Broering, President of Early Clinical and Bioanalytical Solutions contribute to this feature in BioPharm International, which looks at how novel solutions and improvements aimed at benefitting the drug development process with the right framework are coming to the fore.
Murphy, J.Moving Closer to Dynamic Drug Development. BioPharm International 36 (6) 2023.
-
Endpoints News LGBTQ+ Biopharma Leaders '23
Jon Newton, Vice President, Corporate Development, Innovative Partnerships & Strategic Healthcare is featured in this report which profiles a group of scientists, executives, founders and academics who are leading the way for LGBTQ+ inclusion in the drug development industry.
© Endpoints News 2023
-
Disease surveillance and vaccine development
In this article in Life Science Review, Dinah Knotts, Vice President, project management, Vaccines and Infectious Disease, ICON plc outlines how disease surveillance can play an important role in emerging infectious disease early.
-
Realising the benefits of bringing the trial to the patient
In this article in Clinical Research News, Ashmee Bharadia, Vice President for Accellacare in Home Services, outlines how in-home services are being baked into trials because of their value in supporting patient-centric trials with decentralised components.
-
The most explored endpoints in decentralised clinical trials
Harpreet Gill, Vice President of Decentralised Clinical Trials and Keith Thomas, Senior Director, Digital Health Technologies contribute to this article in Clinical Trials Arena that investigates decentralisation from the perspective of trial endpoints or outcome measures.
-
Transfer of marketing authorisation
In this interview with BioPharma Reporter, Alma Salibasic, Regulatory Affairs Manager, discusses the role of a Marketing Authorisation Transfer during mergers and acquisitions in the bio pharma industry.
